Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
payerwhitepaper-memotext

payerwhitepaper-memotext

Ratings: (0)|Views: 0|Likes:
Published by SteveEpstein

More info:

Published by: SteveEpstein on Feb 06, 2013
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

06/21/2014

pdf

text

original

 
 
MEMOTEXT.
COM
|1877.MEMO.TXT
 
|
 
USA|
 
C
ANADA
|
 
UK|
 
EU|
 
AUS|
 
@
MEMOTEXT
|
1
The Economic Burden to Managed CareOrganizations of Medication Non-Compliance in Cardiovascular Disease andDiabetes
in association with
Amos Adler M.Sc., CEOMEMOTEXT
amos@memotext.com
 Aaron Davis, Partner/PresidentMetabolic Markets, LLC
aaron@metabolicmarkets.com
 
 
 
MEMOTEXT.
COM
|1877.MEMO.TXT
 
|
 
USA|
 
C
ANADA
|
 
UK|
 
EU|
 
AUS|
 
@
MEMOTEXT
|
2
Summary
: The economic costs of patient non-compliance are well established,driven by expensive chronic disease states such as cardiovascular diseases anddiabetes. The economic impact of patient non-compliance is borne bymanaged care organizations through wasted pharmacy dispensing and theadditional costs incurred from poor clinical outcomes. Adding to this cost is thelost benefit to improve Medicare STAR ratings and PPACA identified qualitymeasurements, several of which are specific to clinical management ofdiabetes and hypertension, where patient compliance is a considerablechallenge.Patient non-compliance has multiple and varied rationales. Health systemshave tried different modalities to improve compliance, but historical efforts haveresulted in limited success. Traditional compliance improvement modalities areeither not individualized to the patient or are not economically feasible for largepopulations. Improving medication compliance through the use of advancedtechnology integrated with behavioral health evidence has advanced toengage individual patients and personalized compliance communications area solution. One technology is the MEMOTEXT Personalized Adherence Solutions,addressing the unmet need to individualize patient communication with provenresults.
 
 
MEMOTEXT.
COM
|1877.MEMO.TXT
 
|
 
USA|
 
C
ANADA
|
 
UK|
 
EU|
 
AUS|
 
@
MEMOTEXT
|
3
Economic burden of medication non-compliance
It is well established that the healthcare system bears a tremendous financialstrain due to patient a lack of adherence to prescribed pharmacologictreatments. Commonly cited data include:
 
~$290 billion for avoidable medical treatment due to nonadherence
1
 
 
> $100 billion spent each year on avoidable hospitalizations
2
 A fundamental driver of the high cost of nonadherence is the broad prevalenceof complicated and costly chronic diseases. Chronic disease treatmentrepresents 75% of US healthcare costs
1
. Over 50% of the U.S. population suffersfrom at least one chronic disease, with cardiovascular risk patients and diabetesparticularly burdensome.
Causes of non-compliance
Medication compliance is complicated due to the multiple and overlappingroot causes. Primary reasons vary among patients and may be intentional ornon-intentional. Patient population and disease state characteristics furthercomplicate understanding the drivers of nonadherence.

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->